The Beauty Health Company (NASDAQ:SKIN) Given Average Recommendation of “Hold” by Brokerages

Shares of The Beauty Health Company (NASDAQ:SKIN) have received an average recommendation of “Hold” from the eight research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $2.42.

Several research firms have recently weighed in on SKIN. Zacks Research upgraded shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday, March 16th. Benchmark reiterated a “hold” rating on shares of Beauty Health in a research note on Friday, March 13th. Canaccord Genuity Group restated a “hold” rating and issued a $1.50 price objective on shares of Beauty Health in a research report on Friday, March 13th. TD Cowen cut their price objective on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a research report on Monday, March 16th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $1.60 price objective on shares of Beauty Health in a research report on Wednesday, January 14th.

Hedge Funds Weigh In On Beauty Health

A number of large investors have recently modified their holdings of SKIN. Woodline Partners LP lifted its position in Beauty Health by 255.9% during the third quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock valued at $11,801,000 after purchasing an additional 4,263,997 shares during the last quarter. Millennium Management LLC lifted its position in Beauty Health by 127.0% during the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after purchasing an additional 3,225,668 shares during the last quarter. Mirabella Financial Services LLP lifted its position in Beauty Health by 21.3% during the third quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after purchasing an additional 2,734,728 shares during the last quarter. Soleus Capital Management L.P. bought a new stake in Beauty Health during the second quarter valued at approximately $1,910,000. Finally, Geode Capital Management LLC lifted its position in Beauty Health by 27.5% during the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock valued at $4,399,000 after purchasing an additional 496,963 shares during the last quarter. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Price Performance

SKIN opened at $0.90 on Friday. The company has a market capitalization of $114.71 million, a price-to-earnings ratio of -4.49 and a beta of 1.24. The company has a quick ratio of 1.40, a current ratio of 1.66 and a debt-to-equity ratio of 3.94. The firm has a 50-day moving average price of $1.06 and a 200-day moving average price of $1.34. Beauty Health has a twelve month low of $0.76 and a twelve month high of $2.69.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. The firm had revenue of $82.37 million during the quarter, compared to the consensus estimate of $78.07 million. Beauty Health had a negative net margin of 3.16% and a negative return on equity of 15.40%. Equities analysts expect that Beauty Health will post -0.25 EPS for the current year.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.